Metraipolis › archive › dc_2e2243079db9

Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-08T16:09:58.374Z
SHA-256 of the archived text
caa3a3f269c069ac6d1775cc4b8e28af5ce532464089560f8d9caa676f33bee5
Stable URL of this page
https://metraipolis.com/documento/dc_2e2243079db9

How to cite

Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_2e2243079db9 (Metraipolis archive dc_2e2243079db9, sha256 caa3a3f269c069ac6d1775cc4b8e28af5ce532464089560f8d9caa676f33bee5)
BibTeX
@misc{dc2e2243079db9,
  title = {Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_2e2243079db9; sha256 caa3a3f269c069ac6d1775cc4b8e28af5ce532464089560f8d9caa676f33bee5},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel is an cancer treatment for use in hematopoietic stem cell transplantation. It is composed of two distinct cellular components both derived from umbilical cord blood. It was authorized for medical use in the European Union in August 2025. The first component is dorocubicel, which consists of CD34+ hematopoietic stem cells that have been expanded ex vivo in cell culture using the small molecule UM171. UM171 is a pyrimido-indole derivative shown to enhance the self-renewal capacity and proliferative potential of hematopoietic stem cells while preserving their undifferentiated state, or multipotency. Expansion of CD34+ cells aims to accelerate engraftment and improve immune system reconstitution following transplantation. The second component consists of non-expanded CD34− cells, which are a heterogeneous population of umbilical cord blood-derived cells that may include supportive stromal or immune-modulating cell types. These cells are not manipulated in culture prior to administration and are believed to contribute to the overall graft function and engraftment process through paracrine signaling.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel» — https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel
Wikidata Q135287405 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q135287405
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Allogeneic_umbilical_cord-derived_CD34-_cells,_non-expanded/dorocubicel?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1335719571, consultata il 2026-11-08T16:06:07.245Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 6e21efcf598a3f4505284f052a20759a1ee9fe256473010a628ea61be28d43e1